cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.4re9m8
title: Occurrence Download

description: A dataset containing 765593 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is Xeno-canto - Bird sounds from around the world"
 ]
}

 The dataset includes 765593 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010010-250426092105405/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.7910/dvn/isngbd
title: sadasdasdasdasdad

description: sadsadasdfdaslkfjkhasdfiohaoisdfhojsdnv;ja;sdhouvhovn ;zjhx oihoidsaf;lknsdvoihSODIVLXVCN UOHfoihd;lskdvnoiSHDFIX CLNOI\FHDIO\SXCM\NIOXFHi\sdfkl\vndcpivhj\pdvj;dz,xmvipj\dpijm\zn xcih\veidfcnlk'\xnvci\hd
DOI: 10.7910/dvn/sjxw4t
title: A13_26043.jpg

description: Link to OCHRE database: &lt;a href = 'http://pi.lib.uchicago.edu/1001/org/ochre/5453c5c8-3614-4e96-b900-eb7ffd2f42c4'&gt;http://pi.lib.uchicago.edu/1001/org/ochre/5453c5c8-3614-4e96-b900-eb7ffd2f42c4
DOI: 10.7910/dvn/x2lmma
title: Executive Agreements Database, Statement Regarding Agreement Between The United States and Bulgaria Concerning Economic, Technical And Related Assistance Signed At Sofia July 27, 1998 Entered Into Force February 1, 1999

description: TIAS 12979

cover memo
DOI: 10.7910/dvn/wvxm26
title: A14_27075.jpg

description: Link to OCHRE database: &lt;a href = 'http://pi.lib.uchicago.edu/1001/org/ochre/a2d61036-c4ce-4660-bc92-3f4976463f0e'&gt;http://pi.lib.uchicago.edu/1001/org/ochre/a2d61036-c4ce-4660-bc92-3f4976463f0e
DOI: 10.5281/zenodo.15318697
title: TaktPixel2025PD-CD: Taktpixel 2025 Printing Defect Change Detection Dataset

description: TaktPixel2025PD-CD is a dataset for evaluating change detection models in the domain of industrial printing inspection. It contains image pairs of printed materials scanned from both offset and inkjet print samples. Each image pair includes:



A master image (reference, assumed defect-free)

A target image (possibly containing a defect)

A pixel-wise binary mask representing the defect region


The dataset is divided into train, val, and test splits, and organized into the standard A/, B/, and OUT/ folder structure commonly used in change detection tasks.

Six common defect types are labeled:



Black spot

Color shift

Friction

Hair

Line

Pinhole


Candidate defect regions were extracted using comparative image inspection techniques and manually validated through expert review. Ground-truth masks are refined to exclude false positives caused by normal printing variation.

This dataset is released under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. It is suitable for training and benchmarking machine learning models, particularly for applications in visual inspection and quality assurance in the printing industry.
DOI: 10.5281/zenodo.15318802
title: Taktpixel2025PD-CD: Taktpixel 2025 Printing Defect Change Detection Dataset

description: Taktpixel2025PD-CD is a dataset for evaluating change detection models in the domain of industrial printing inspection. It contains image pairs of printed materials scanned from both offset and inkjet print samples. Each image pair includes:



A master image (reference, assumed defect-free)

A target image (possibly containing a defect)

A pixel-wise binary mask representing the defect region


The dataset is divided into train, val, and test splits, and organized into the standard A/, B/, and OUT/ folder structure commonly used in change detection tasks.

Six common defect types are labeled:



Black spot

Color shift

Friction

Hair

Line

Pinhole


Candidate defect regions were extracted using comparative image inspection techniques and manually validated through expert review. Ground-truth masks are refined to exclude false positives caused by normal printing variation.

This dataset is released under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. It is suitable for training and benchmarking machine learning models, particularly for applications in visual inspection and quality assurance in the printing industry.
DOI: 10.5281/zenodo.15318914
title: Bibliographic Dataset for the Regenerative Retrofitting Via Ecologically Active Soil Structures (Reeco-Soil) Research Project

description: This database contains all the bibliographic information found after applying the Search Strategy used for the Regenerative Retrofitting Via Ecologically Active Soil Structures (Reeco-Soil) Systematic Literature Review. The following electronic databases were searched:



Scopus.

Web of Science


A total of 908 records were found. The search was conducted on 30/04/2025.

The information is presented in .ris, .bib, and .csv format.
DOI: 10.5281/zenodo.15318915
title: Bibliographic Dataset for the Regenerative Retrofitting Via Ecologically Active Soil Structures (Reeco-Soil) Research Project

description: This database contains all the bibliographic information found after applying the Search Strategy used for the Regenerative Retrofitting Via Ecologically Active Soil Structures (Reeco-Soil) Systematic Literature Review. The following electronic databases were searched:



Scopus.

Web of Science


A total of 908 records were found. The search was conducted on 30/04/2025.

The information is presented in .ris, .bib, and .csv format.
DOI: 10.5281/zenodo.7566163
title: Dataset for the Moesin antibody screening study

description: This antibody characterization dataset is related to the F1000 research article openly available at F1000Research.

This project contains the following underlying data included in a study aiming at characterizing antibodies for the Moesin protein, encoded by the MSN gene. The original study is also available on the Zenodo YCharOS community (https://doi.org/10.5281/zenodo.4724169).
DOI: 10.5281/zenodo.7566164
title: Dataset for the Moesin antibody screening study

description: This antibody characterization dataset is related to the F1000 research article openly available at F1000Research.

This project contains the following underlying data included in a study aiming at characterizing antibodies for the Moesin protein, encoded by the MSN gene. The original study is also available on the Zenodo YCharOS community (https://doi.org/10.5281/zenodo.4724169).
DOI: 10.5281/zenodo.15318696
title: Taktpixel2025PD-CD: Taktpixel 2025 Printing Defect Change Detection Dataset

description: Taktpixel2025PD-CD is a dataset for evaluating change detection models in the domain of industrial printing inspection. It contains image pairs of printed materials scanned from both offset and inkjet print samples. Each image pair includes:



A master image (reference, assumed defect-free)

A target image (possibly containing a defect)

A pixel-wise binary mask representing the defect region


The dataset is divided into train, val, and test splits, and organized into the standard A/, B/, and OUT/ folder structure commonly used in change detection tasks.

Six common defect types are labeled:



Black spot

Color shift

Friction

Hair

Line

Pinhole


Candidate defect regions were extracted using comparative image inspection techniques and manually validated through expert review. Ground-truth masks are refined to exclude false positives caused by normal printing variation.

This dataset is released under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. It is suitable for training and benchmarking machine learning models, particularly for applications in visual inspection and quality assurance in the printing industry.
DOI: 10.5281/zenodo.15318946
title: Taktpixel2025PD-CD: Taktpixel 2025 Printing Defect Change Detection Dataset

description: Taktpixel2025PD-CD is a dataset for evaluating change detection models in the domain of industrial printing inspection. It contains image pairs of printed materials scanned from both offset and inkjet print samples. Each image pair includes:



A master image (reference, assumed defect-free)

A target image (possibly containing a defect)

A pixel-wise binary mask representing the defect region


The dataset is divided into train, val, and test splits, and organized into the standard A/, B/, and OUT/ folder structure commonly used in change detection tasks.

Six common defect types are labeled:



Black spot

Color shift

Friction

Hair

Line

Pinhole


Candidate defect regions were extracted using comparative image inspection techniques and manually validated through expert review. Ground-truth masks are refined to exclude false positives caused by normal printing variation.

This dataset is released under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. It is suitable for training and benchmarking machine learning models, particularly for applications in visual inspection and quality assurance in the printing industry.
DOI: 10.7910/dvn/hkhoda
title: Executive Agreements Database, Statement Concerning the Agreement with Uganda Concerning the Program of the Peace Corps In The Republic Of Uganda Signed At Kampala December 10, 2007 Entered Into Force December 10, 2007

description: TIAS 07-1210

First signed 12/10/2007
Last signed 12/10/2007
Entry into force (supplemented by last signed) 12/10/2007

CAR 2008-011

stamped 08-011

C06572643

cover memo
DOI: 10.5281/zenodo.6914815
title: Dataset for the TBK1 antibody screening study

description: This antibody characterization dataset is related to the F1000 research article openly available at F1000Research.

This project contains the following underlying data included in a study aiming at characterization antibodies for the serine/threonine-protein kinase (TBK1) protein, encoded by the TBK1 gene. The original study is also available on the Zenodo YCharOS community (https://doi.org/10.5281/zenodo.6402968) and on BioRxiv (https://doi.org/10.1101/2022.06.03.494699).

File name is presented as "database number"_"company catalogue number".
DOI: 10.5281/zenodo.6914816
title: Dataset for the TBK1 antibody screening study

description: This antibody characterization dataset is related to the F1000 research article openly available at F1000Research.

This project contains the following underlying data included in a study aiming at characterization antibodies for the serine/threonine-protein kinase (TBK1) protein, encoded by the TBK1 gene. The original study is also available on the Zenodo YCharOS community (https://doi.org/10.5281/zenodo.6402968) and on BioRxiv (https://doi.org/10.1101/2022.06.03.494699).

File name is presented as "database number"_"company catalogue number".
DOI: 10.5281/zenodo.15238146
title: Passive acoustic monitoring reveals surprising patterns of avian community antipredator behavior at a landscape scale

description: The purpose of this study was to investigate how birds in the Sierra Nevada vocally respond to goshawk calls. The data were collected as part of a long-term passive acoustic monitoring project originally designed to monitor Spotted Owls (see Kelly et al. 2023, Ecological Indicators 154:110851).

Recordings were collected with Swift One autonomous recording units deployed in mixed conifer forest across 25,000 km2 of the Western slope of the Sierra Nevada. The present study only used audio collected in 2021 between the hours of 4:00-10:00 and 18:00-21:00. Calls were detected and identified to species using the artificial neural network BirdNET. The present data set consists of 5 .csv files with data and 1 .R file with code used to analyze those data.
DOI: 10.5281/zenodo.15318953
title: Passive acoustic monitoring reveals surprising patterns of avian community antipredator behavior at a landscape scale

description: The purpose of this study was to investigate how birds in the Sierra Nevada vocally respond to goshawk calls. The data were collected as part of a long-term passive acoustic monitoring project originally designed to monitor Spotted Owls (see Kelly et al. 2023, Ecological Indicators 154:110851).

Recordings were collected with Swift One autonomous recording units deployed in mixed conifer forest across 25,000 km2 of the Western slope of the Sierra Nevada. The present study only used audio collected in 2021 between the hours of 4:00-10:00 and 18:00-21:00. Calls were detected and identified to species using the artificial neural network BirdNET. The present data set consists of 5 .csv files with data and 1 .R file with code used to analyze those data.
DOI: 10.7910/dvn/fmgbyb
title: A11_18932.jpg

description: Link to OCHRE database: &lt;a href = 'http://pi.lib.uchicago.edu/1001/org/ochre/77e44478-324b-45bb-98a6-b461dba37eed'&gt;http://pi.lib.uchicago.edu/1001/org/ochre/77e44478-324b-45bb-98a6-b461dba37eed
DOI: 10.7910/dvn/wymqxe
title: A88_1863.jpg

description: Link to OCHRE database: &lt;a href = 'http://pi.lib.uchicago.edu/1001/org/ochre/e8c93141-7ed0-fb8e-0d40-77f841d002f2'&gt;http://pi.lib.uchicago.edu/1001/org/ochre/e8c93141-7ed0-fb8e-0d40-77f841d002f2
DOI: 10.7910/dvn/sbnxwr
title: A15_27332.jpg

description: Link to OCHRE database: &lt;a href = 'http://pi.lib.uchicago.edu/1001/org/ochre/07ddd988-e07d-4272-856c-223d0305a4c2'&gt;http://pi.lib.uchicago.edu/1001/org/ochre/07ddd988-e07d-4272-856c-223d0305a4c2
DOI: 10.5281/zenodo.14847839
title: National Scale Above-Ground Biomass in Nepal's Forests at 10m Resolution (Circa 2020)

description: AGB mapping in Nepal's forests circa 2020 at 10m resolution using Sentinel-1, Sentinel-2, and field data in the Google Earth Engine.

The CART model achieved 92% accuracy (R² = 0.92), with RMSE of 30.42 Mg ha⁻¹ and MAE of 18.84 Mg ha⁻¹.

2,834 field-measured AGB samples were used to train and validate the machine learning model.

Nepal's total tree cover AGB is estimated at 132 Pg, with a mean value of 150.32 Mg ha⁻¹ and maximum of 452.05 Mg ha⁻¹.

High uncertainty in mountainous areas; low uncertainty in dense forests, aiding conservation strategies.

The study supports REDD+ initiatives and sustainable forest management with open-access AGB data.
DOI: 10.5281/zenodo.7530472
title: Dataset for the Midkine antibody screening study

description: This project contains the following underlying data included in a study aiming at characterization antibodies for the Midkine protein. The study is available on Zenodo (https://doi.org/10.5281/zenodo.5644321).
DOI: 10.7910/dvn/2dcbgd
title: Replication Data for: PLOS ONE 20250326

description: CLASS
DOI: 10.7910/dvn/n0l6hz
title: Replication Data for Is Financial Autonomy Beneficial for Publicly-Funded Research: Evidence from Top Chinese Institutions

description: Data and code used in the paper entitled "Is Financial Autonomy Beneficial for Publicly-Funded Research: Evidence from Top Chinese Institutions"
DOI: 10.25934/00000166
title: A Randomized, Double-Blind, Parallel Group, 52-Week Study to Compare the Effect of Fluticasone Propionate/Salmeterol Diskus Combination Product 250/50mcg BID With Salmeterol Diskus 50mcg BID on the Annual Rate of Moderate/Severe Exacerbations in Subjects With Chronic Obstructive Pulmonary Disease

description: This study evaluates the effect of two medicines on COPD (Chronic Obstructive Pulmonary Disease) exacerbations. This study will last up to 56 weeks, and subjects will visit the clinic 10 times. Subjects will be given breathing tests and will record their breathing symptoms daily on diary cards. All study related medicines and medical examinations will be provided at no cost. The two drugs used in this study have been approved by FDA for use in patients with COPD.
DOI: 10.25934/00000207
title: A Randomized, Double-Blind, Parallel Group, 52-Week Study to Compare the Effect of Fluticasone Propionate/Salmeterol DISKUS® Inhaler Combination Product 250/50mcg Twice Daily With Salmeterol DISKUS® Inhaler 50mcg Twice Daily on the Annual Rate of Moderate/Severe Exacerbations in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

description: This study evaluates the effect of two medicines on COPD (Chronic Obstructive Pulmonary Disease) exacerbations. This study will last up to 56 weeks, and subjects will visit the clinic 10 times. Subjects will be given breathing tests and will record their breathing symptoms daily on diary cards. All study related medicines and medical examinations will be provided at no cost. The two drugs used in this study have been approved by the FDA for use in patients with COPD.
DOI: 10.25934/00000269
title: A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Long-term Effects of Salmeterol/Fluticasone Propionate (Seretide tm) 50/500mcg BD, Salmeterol 50mcg BD and Fluticasone Propionate 500mcg BD, All Delivered Via the Diskus tm/Accuhaler tm Inhaler, on Mortality and Morbidity of Subjects With Chronic Obstructive Pulmonary Disease (COPD) Over 3 Years of Treatment

description: The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the survival of subjects with COPD and also assess the long term safety profile of this drug.
DOI: 10.25934/00000869
title: HZC102970: A 52-week Efficacy and Safety Study to Compare the Effect of Three Dosage Strengths of Fluticasone Furoate/GW642444 Inhalation Powder With GW642444 on the Annual Rate of Exacerbations in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

description: The Purpose of this study is to assess the efficacy and safety of three strengths of the FF/GW642444 Inhalation Powder in subject with Chronic Obstructive Pulmonary Disease (COPD)
DOI: 10.25934/00000893
title: A 24-Week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components Delivered Once Daily (AM) Via a Novel Dry Powder Inhaler Compared With Placebo in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

description: The Purpose of this study is to assess the efficacy and safety of two strengths of the FF/GW642444 Inhalation Powder in subjects with chronic obstructive pulmonary disease (COPD)
DOI: 10.25934/00000894
title: A 24-Week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components Delivered Once Daily (AM) Via a Novel Dry Powder Inhaler Compared With Placebo in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

description: The Purpose of this study is to assess the efficacy and safety of two strengths of the FF/GW642444 Inhalation Powder in subject with Chronic Obstructive Pulmonary Disease (COPD)
DOI: 10.25934/00001315
title: A 12-Week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) 100/25 mcg Once Daily Compared With Vilanterol Inhalation Powder (VI) 25 mcg Once Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

description: This is a Phase IIIa, multicenter, randomized, stratified (reversibility status), double-blind, parallel-group study to evaluate the efficacy and safety of FF/VI 100/25 micrograms (mcg) once daily (QD) compared with VI 25 mcg QD, administered in the morning via the ELLIPTA™ inhaler. The primary objective of this study is to evaluate the contribution on lung function (as measured by trough forced expiratory volume in one second [FEV1]) of FF 100 mcg to the FF/VI 100/25 mcg QD combination by comparison of the latter with VI 25 mcg QD and the safety of FF/VI 100/25 mcg over a 12-week treatment period in subjects with COPD. ELLIPTA™ is a registered trademark of GlaxoSmithKline.
DOI: 10.25934/00001323
title: A Phase III, 52 Week, Randomized, Double-blind, 3-arm Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination FF/UMEC/VI With the Fixed Dose Dual Combinations of FF/VI and UMEC/VI, All Administered Once-daily in the Morning Via a Dry Powder Inhaler in Subjects With Chronic Obstructive Pulmonary Disease

description: The study evaluates the efficacy of fluticasone furoate/umeclidinium bromide/vilanterol (FF/UMEC/VI) to reduce the annual rate of moderate and severe exacerbations compared with dual therapy of FF/VI or UMEC/VI in subjects with COPD. Published studies which assessed the use of an 'open' triple therapy (use of Inhaled Corticosteroid [ICS]/ Long-acting Muscarinic Receptor Antagonists [LAMA])/ Long Acting Beta-Agonist [LABA] delivered via multiple inhalers) in moderate-severe COPD patients, reported improvements in lung function, Health Related Quality of Life (HRQoL), hospitalization rates and rescue medication use, compared to dual therapy (ICS/LABA) or LAMA alone. These studies have also shown similar safety profile with dual or monotherapy doses for periods of up to one year. Given the clinical experience with FF, UMEC and VI, and that the associated risks with these compounds are anticipated from their known pharmacology, the potential benefit of a new therapy option in patients with moderate to severe COPD supports the further development of the closed triple combination (delivered via one inhaler). In the current study subjects meeting all inclusion/exclusion criteria will complete 2-week run-in period; 52 week treatment period and a 1-week safety follow-up period. Eligible subjects will be randomized to one of the following double-blind treatment groups FF/UMEC/VI 100 micrograms (mcg)/62.5 mcg/25 mcg once daily (QD), FF/VI 100 mcg/25 mcg QD, or UMEC/VI 62.5 mcg/25 mcg QD
DOI: 10.25934/00002291
title: A randomized, double-blind, parallel-group, comparative trial of inhaled fluticasone propionate 250mcg twice daily, 500mcg twice daily, and placebo twice daily via the DISKUS� inhaler in subjects with chronic obstructive pulmonary disease (COPD).

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002292
title: A multicentre, double-blind, placebo-controlled, parallel group study of the efficacy and tolerability of long-term inhaled fluticasone propionate 500mg twice daily via a Volumatic Spacer device in patients with non-asthmatic chronic obstructive pulmonary disease, including�

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002301
title: A randomized, double-blind, placebo-controlled, parallel-group, trial evaluating the safety and efficacy of the Diskus formulations of salmeterol 50mcg twice daily and fluticasone propionate 500mcg twice daily individually and in combination as compared to placebo in COPD patients.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.